Madrigal Pharmaceuticals, Inc. (MDGL)
427.18
+1.97
(+0.46%)
USD |
NASDAQ |
Nov 13, 16:00
427.18
0.00 (0.00%)
After-Hours: 19:59
Madrigal Pharmaceuticals Market Cap : 9.920B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 9.874B |
| November 11, 2026 | 10.06B |
| November 10, 2026 | 10.05B |
| November 09, 2026 | 10.05B |
| November 06, 2026 | 9.280B |
| November 05, 2026 | 9.291B |
| November 04, 2026 | 9.299B |
| November 03, 2026 | 9.203B |
| November 02, 2026 | 10.01B |
| October 30, 2026 | 9.994B |
| October 29, 2026 | 9.970B |
| October 28, 2026 | 9.954B |
| October 27, 2026 | 10.17B |
| October 26, 2026 | 10.11B |
| October 23, 2026 | 10.03B |
| October 22, 2026 | 10.47B |
| October 21, 2026 | 10.58B |
| October 20, 2026 | 10.80B |
| October 19, 2026 | 10.33B |
| October 16, 2026 | 10.39B |
| October 15, 2026 | 10.62B |
| October 14, 2026 | 10.62B |
| October 13, 2026 | 10.44B |
| October 12, 2026 | 10.79B |
| October 09, 2026 | 10.89B |
| Date | Value |
|---|---|
| October 08, 2026 | 11.01B |
| October 07, 2026 | 11.26B |
| October 06, 2026 | 11.47B |
| October 05, 2026 | 11.40B |
| October 02, 2026 | 11.53B |
| October 01, 2026 | 11.54B |
| September 30, 2026 | 11.64B |
| September 29, 2026 | 11.77B |
| September 28, 2026 | 11.94B |
| September 25, 2026 | 11.93B |
| September 24, 2026 | 11.85B |
| September 23, 2026 | 11.85B |
| September 22, 2026 | 11.98B |
| September 21, 2026 | 12.05B |
| September 18, 2026 | 12.27B |
| September 17, 2026 | 12.34B |
| September 16, 2026 | 12.22B |
| September 15, 2026 | 12.08B |
| September 14, 2026 | 12.47B |
| September 11, 2026 | 12.34B |
| September 10, 2026 | 12.31B |
| September 09, 2026 | 12.62B |
| September 08, 2026 | 12.34B |
| September 04, 2026 | 12.50B |
| September 03, 2026 | 12.53B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 26.57B |
| Alnylam Pharmaceuticals, Inc. | 22.09B |
| Arrowhead Pharmaceuticals, Inc. | 6.741B |
| Cytokinetics, Inc. | 7.806B |
| United Therapeutics Corp. | 25.05B |
Market Cap Related Metrics
| PS Ratio | 8.326 |
| Price to Book Value | 15.82 |
| Price | 427.18 |
| Earnings Yield | -1.40% |